Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Recruiting

Phase 2

Chemoradiation vs. ImmunotherapyChemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Sponsor:

Loren Mell, MD

Code:

NCT03383094

Conditions

Head and Neck Squamous Cell Carcinoma

Cancer

Cancer of Head and Neck

Cancer, Advanced

Cancer, Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Radiation therapy

Cisplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Loren Mell, MD on 2024-08-06.